Covered recipient · General Payments record
KYLE L CLIFFORD
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,942.69
- Reported across 175 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $578.53 | 30 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $191.27 | 9 |
| Amgen Inc. | $84.52 | 5 |
| Astellas Pharma US Inc | $74.07 | 3 |
| Lilly USA, LLC | $45.59 | 3 |
| Novo Nordisk AS | $38.81 | 2 |
| Phathom Pharmaceuticals, Inc. | $37.67 | 2 |
| PFIZER INC. | $31.43 | 2 |
| Acerta Pharma LLC | $29.73 | 2 |
| Vanda Pharmaceuticals Inc. | $28.15 | 1 |
| Corcept Therapeutics | $17.29 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (30)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.54 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103480493 | CMS |
| ABBVIE INC. | $20.76 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103480495 | CMS |
| ABBVIE INC. | $31.45 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103480497 | CMS |
| ABBVIE INC. | $30.08 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103480499 | CMS |
| ABBVIE INC. | $25.06 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103480501 | CMS |
| ABBVIE INC. | $15.77 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103480503 | CMS |
| ABBVIE INC. | $20.08 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103480505 | CMS |
| ABBVIE INC. | $15.24 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103480507 | CMS |
| ABBVIE INC. | $4.29 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103480509 | CMS |
| Amgen Inc. | $16.50 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111551396 | CMS |
| Amgen Inc. | $15.11 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111551398 | CMS |
| Amgen Inc. | $14.00 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111551400 | CMS |
| Amgen Inc. | $25.00 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111551402 | CMS |
| Amgen Inc. | $13.91 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111551404 | CMS |
| Astellas Pharma US Inc | $27.08 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139323594 | CMS |
| Astellas Pharma US Inc | $26.08 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139423943 | CMS |
| Astellas Pharma US Inc | $20.91 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139439706 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.66 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104643301 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.07 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105878293 | CMS |
| Corcept Therapeutics | $17.29 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117750693 | CMS |
| Lilly USA, LLC | $16.79 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135121747 | CMS |
| Lilly USA, LLC | $13.55 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135129358 | CMS |
| Lilly USA, LLC | $15.25 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135081774 | CMS |
| Novo Nordisk Inc | $18.65 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096927272 | CMS |
| Novo Nordisk Inc | $20.16 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096681549 | CMS |
| PFIZER INC. | $15.21 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131907352 | CMS |
| PFIZER INC. | $16.22 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131918933 | CMS |
| Phathom Pharmaceuticals, Inc. | $22.74 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151050771 | CMS |
| Phathom Pharmaceuticals, Inc. | $14.93 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151050773 | CMS |
| Vanda Pharmaceuticals Inc. | $28.15 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133899855 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.